Incidence of Cutaneous Reactions After Messenger RNA COVID-19 Vaccines

doi:10.1001/jamadermatol.2021.2114

Comparative Study

. 2021 Aug 1;157(8):1000-1002.

doi: 10.1001/jamadermatol.2021.2114.

Incidence of Cutaneous Reactions After Messenger RNA COVID-19 Vaccines

Lacey B Robinson¹, Xiaoqing Fu¹, Dean Hashimoto², Paige Wickner³, Erica S Shenoy¹, Adam B Landman³, Kimberly G Blumenthal¹

Affiliations

¹ Massachusetts General Hospital, Boston.
² Mass General Brigham, Sommerville, Massachusetts.
³ Brigham and Women's Hospital, Boston, Massachusetts.

PMID: 34160555
PMCID: PMC8223130
DOI: 10.1001/jamadermatol.2021.2114

Comparative Study

Incidence of Cutaneous Reactions After Messenger RNA COVID-19 Vaccines

Lacey B Robinson et al. JAMA Dermatol. 2021.

. 2021 Aug 1;157(8):1000-1002.

doi: 10.1001/jamadermatol.2021.2114.

Authors

Lacey B Robinson¹, Xiaoqing Fu¹, Dean Hashimoto², Paige Wickner³, Erica S Shenoy¹, Adam B Landman³, Kimberly G Blumenthal¹

Affiliations

¹ Massachusetts General Hospital, Boston.
² Mass General Brigham, Sommerville, Massachusetts.
³ Brigham and Women's Hospital, Boston, Massachusetts.

PMID: 34160555
PMCID: PMC8223130
DOI: 10.1001/jamadermatol.2021.2114

Abstract

This cohort study examines cutaneous reactions in hospital employees who received messenger RNA COVID-19 vaccination.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Blumenthal reports grants from the American Academy of Allergy Asthma and Immunology Foundation, CRICO, and Massachusetts General Hospital outside the submitted work. Dr Landman reports personal fees from Abbott Medical Device Cybersecurity Council outside the submitted work. Dr Wickner reports employment with CVS Health outside the submitted work. No other disclosures were reported.

Figures

See this image and copyright information in PMC

Cited by

Serious adverse events following immunization with COVID-19 vaccines in Lebanon: a retrospective analysis of the National Pharmacovigilance Database.
Karam R, Iskandar K, Watfa M, Zeitoun A. Karam R, et al. BMC Public Health. 2024 Oct 21;24(1):2905. doi: 10.1186/s12889-024-20297-z. BMC Public Health. 2024. PMID: 39434043 Free PMC article.
Safety of COVID-19 Vaccines among People with History of Allergy: A European Active Surveillance Study.
Luxi N, Ciccimarra F, Bellitto C, Raethke M, van Hunsel F, Lieber T, Mulder E, L'Abbate L, Marques FB, Furci F, Farcas A, Giele-Eshuis J, Morton K, Sonderlichová S, Thurin NH, Villalobos F, Riefolo F, Sturkenboom MC, Trifirò G. Luxi N, et al. Vaccines (Basel). 2024 Sep 17;12(9):1059. doi: 10.3390/vaccines12091059. Vaccines (Basel). 2024. PMID: 39340089 Free PMC article.
Multicentric observational study of the possible side effects of the COVID-19 vaccine in relation to absorbable thread insertion.
Poleva I, Szomolai E, Hegedus B, Zhukova O. Poleva I, et al. J Cutan Aesthet Surg. 2024 Apr-Jun;17(2):100-104. doi: 10.4103/JCAS.JCAS_93_23. J Cutan Aesthet Surg. 2024. PMID: 38800814 Free PMC article.
Cutaneous Reactions after COVID-19 Vaccines: Analysis of the Clinical and Histopathological Spectrum-Case Series and Review of the Literature.
Schmid U, Galambos J, Pfaltz K, Hegyi I, Courvoisier S, Kempf W. Schmid U, et al. Dermatopathology (Basel). 2024 Mar 14;11(1):130-141. doi: 10.3390/dermatopathology11010013. Dermatopathology (Basel). 2024. PMID: 38534266 Free PMC article.
Right Biceps Pseudo-Tumor from COVID-19 Vaccination.
Abbas AM, Caicedo ML, Damron TA. Abbas AM, et al. Vaccines (Basel). 2024 Feb 3;12(2):160. doi: 10.3390/vaccines12020160. Vaccines (Basel). 2024. PMID: 38400143 Free PMC article.

See all "Cited by" articles

References

1. Shimabukuro TT, Cole M, Su JR. Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US—December 14, 2020-January 18, 2021. JAMA. 2021;325(11):1101-1102. doi:10.1001/jama.2021.1967 - DOI - PMC - PubMed
1. Blumenthal KG, Freeman EE, Saff RR, et al. . Delayed large local reactions to mRNA-1273 vaccine against SARS-CoV-2. N Engl J Med. 2021;384(13):1273-1277. doi:10.1056/NEJMc2102131 - DOI - PMC - PubMed
1. Blumenthal KG, Li Y, Acker WW, et al. . Multiple drug intolerance syndrome and multiple drug allergy syndrome: Epidemiology and associations with anxiety and depression. Allergy. 2018;73(10):2012-2023. doi:10.1111/all.13440 - DOI - PMC - PubMed
1. McMahon DE, Amerson E, Rosenbach M, et al. . Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases. J Am Acad Dermatol.S0190-9622(21)00658-7. In Press. - PMC - PubMed
1. Kelso JM, Greenhawt MJ, Li JT, et al. . Adverse reactions to vaccines practice parameter 2012 update. J Allergy Clin Immunol. 2012;130(1):25-43. doi:10.1016/j.jaci.2012.04.003 - DOI - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

[1] Shimabukuro TT, Cole M, Su JR. Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US—December 14, 2020-January 18, 2021. JAMA. 2021;325(11):1101-1102. doi:10.1001/jama.2021.1967 - DOI - PMC - PubMed

[2] Shimabukuro TT, Cole M, Su JR. Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US—December 14, 2020-January 18, 2021. JAMA. 2021;325(11):1101-1102. doi:10.1001/jama.2021.1967 - DOI - PMC - PubMed

[3] Blumenthal KG, Freeman EE, Saff RR, et al. . Delayed large local reactions to mRNA-1273 vaccine against SARS-CoV-2. N Engl J Med. 2021;384(13):1273-1277. doi:10.1056/NEJMc2102131 - DOI - PMC - PubMed

[4] Blumenthal KG, Freeman EE, Saff RR, et al. . Delayed large local reactions to mRNA-1273 vaccine against SARS-CoV-2. N Engl J Med. 2021;384(13):1273-1277. doi:10.1056/NEJMc2102131 - DOI - PMC - PubMed

[5] Blumenthal KG, Li Y, Acker WW, et al. . Multiple drug intolerance syndrome and multiple drug allergy syndrome: Epidemiology and associations with anxiety and depression. Allergy. 2018;73(10):2012-2023. doi:10.1111/all.13440 - DOI - PMC - PubMed

[6] Blumenthal KG, Li Y, Acker WW, et al. . Multiple drug intolerance syndrome and multiple drug allergy syndrome: Epidemiology and associations with anxiety and depression. Allergy. 2018;73(10):2012-2023. doi:10.1111/all.13440 - DOI - PMC - PubMed

[7] McMahon DE, Amerson E, Rosenbach M, et al. . Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases. J Am Acad Dermatol.S0190-9622(21)00658-7. In Press. - PMC - PubMed

[8] McMahon DE, Amerson E, Rosenbach M, et al. . Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases. J Am Acad Dermatol.S0190-9622(21)00658-7. In Press. - PMC - PubMed

[9] Kelso JM, Greenhawt MJ, Li JT, et al. . Adverse reactions to vaccines practice parameter 2012 update. J Allergy Clin Immunol. 2012;130(1):25-43. doi:10.1016/j.jaci.2012.04.003 - DOI - PubMed

[10] Kelso JM, Greenhawt MJ, Li JT, et al. . Adverse reactions to vaccines practice parameter 2012 update. J Allergy Clin Immunol. 2012;130(1):25-43. doi:10.1016/j.jaci.2012.04.003 - DOI - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Incidence of Cutaneous Reactions After Messenger RNA COVID-19 Vaccines

Affiliations

Incidence of Cutaneous Reactions After Messenger RNA COVID-19 Vaccines

Authors

Affiliations

Abstract

Conflict of interest statement

Figures

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical